Researchers uncover mechanism of protein GBP1 in immune defense

The protein GBP1 is a vital component of our body’s natural defence against pathogens. This substance fights against bacteria and parasites by enveloping them in a protein coat, but how the substance manages to do this has remained unknown until now.

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer.

May 17, 2024

Exclusive: Emails reveal how health departments struggle to track human cases of bird flu

Bird flu cases have more than doubled in the country within a few weeks, but researchers can’t determine why the spike is happening because surveillance

October 25, 2024

Nxera wins $35m after Phase II schizophrenia trial success – Pharmaceutical Technology

Schizophrenia patients can suffer from both positive and negative symptoms. Credit: Drawlab19 via Shutterstock. Japanese biopharma Nxera Pharma has secured $35m in milestone payments from

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.